IL10RB and neoplasm: Stat3∆/∆ CD103+ cDC1- or Il10rb−/− CD103+ cDC1-vaccinated mice exhibited delayed bilateral tumor growth and increased survival, compared to mice vaccinated with Stat3fl/fl CD103+ cDC1s.